KLRK1 and colorectal carcinoma: Indeed subjects with low circulating NK cell activity have a 10-fold higher risk of developing CRC compared to subjects with high NK cell activity, and the HNK1 NKG2D genotype, associated with high NK cell activity, exerts a protective effect against CRC (57, 58).